FEMY (Femasys) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


FEMY Femasys Inc FEMY
55 GF Score
Price $3.60
GF Value $12.23
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Femasys Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Femasys's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FEMY vs RVP, HBIO, ZJYL: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Femasys's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femasys Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Femasys's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Femasys's Margin of Safety % (DCF FCF Based) falls into.


FEMY
55GF Score
Femasys Inc FEMY
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Femasys (FEMY) Overvalued in 2026?

Based on GuruFocus' analysis, Femasys stock appears to be undervalued. The current stock price of $3.60 is trading 70.6% below its estimated GF Value™ of $12.23. GuruFocus considers Femasys to be Possible Value Trap.

Key valuation signals for FEMY:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $12.23 vs. price of $3.60 (70.6% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the FEMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Femasys Business Description

Address 3950 Johns Creek Court, Suite 100, Suwanee, GA, USA, 30024
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
55GF Score

Get the complete analysis for FEMY

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.60
Price
$12.23
GF Value